Merck and Schering-Plough may have created further risk of injury to patients taking Vytorin by failing to promptly disclose that patients on Vytorin in clinical studies demonstrated increase in plaque deposits in arteries.
Investigation and a pending class action lawsuit against the drug companies Merck & Co. Inc. and Schering-Plough Corporation.
The class action complaint was filed on behalf of all Arizona residents who took VYTORIN, a cholesterol reducing drug.
The class action complaint against Merck and Schering Plough includes claims for consumer fraud and requests medical monitoring for class members under Arizona law.
Recently, Merck and Schering-Plough announced that the data from the ENHANCE clinical trials showed that patients who took VYTORIN (a combination of Zetia and Zocor) actually had an increase in the amount of plaque deposited in their arteries when compared to those patients who took Zocor alone. The data reflects that users of VYTORIN may be more at risk to have a heart attack, and have been exposed to an increased risk of liver damage, than those who took Zocor alone. If you or someone you know is concerned about injuries suffered as a result of taking VYTORIN.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Merck & Co. Inc. (MRK)
Merck & Co. Inc. is a large pharmaceutical company.
Schering-Plough Corporation (SGP)
Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.